M

Mega Lifesciences PCL
SET:MEGA

Watchlist Manager
Mega Lifesciences PCL
SET:MEGA
Watchlist
Price: 27.25 THB 0.93% Market Closed
Market Cap: 23.8B THB

Relative Value

The Relative Value of one MEGA stock under the Base Case scenario is hidden THB. Compared to the current market price of 27.25 THB, Mega Lifesciences PCL is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MEGA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
95
vs Industry
54
Median 3Y
2.2
Median 5Y
2.4
Industry
2.5
Forward
1.6
vs History
95
vs Industry
32
Median 3Y
17.2
Median 5Y
18.5
Industry
21.6
Forward
10.7
vs History
95
vs Industry
33
Median 3Y
16.8
Median 5Y
16.7
Industry
16.7
vs History
90
vs Industry
28
Median 3Y
19.7
Median 5Y
22.9
Industry
24
vs History
95
vs Industry
26
Median 3Y
3.8
Median 5Y
4.3
Industry
2.2
vs History
95
vs Industry
57
Median 3Y
2.1
Median 5Y
2.3
Industry
2.7
Forward
1.4
vs History
95
vs Industry
58
Median 3Y
4.6
Median 5Y
5.5
Industry
5.3
vs History
95
vs Industry
41
Median 3Y
10.4
Median 5Y
13
Industry
12.9
Forward
6.7
vs History
95
vs Industry
42
Median 3Y
11.5
Median 5Y
14.4
Industry
16.3
Forward
7.5
vs History
95
vs Industry
38
Median 3Y
15.5
Median 5Y
15.9
Industry
15.2
vs History
93
vs Industry
30
Median 3Y
17.9
Median 5Y
18
Industry
17.7
vs History
95
vs Industry
26
Median 3Y
3.5
Median 5Y
3.7
Industry
1.9

Multiples Across Competitors

MEGA Competitors Multiples
Mega Lifesciences PCL Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
TH
Mega Lifesciences PCL
SET:MEGA
23.8B THB 1.6 12 5.6 6.1
US
Eli Lilly and Co
NYSE:LLY
738B USD 15.1 66.5 35.7 39
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
374.2B USD 4.2 17.2 12.5 16.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK 6.3 18.4 12.7 14.6
CH
Roche Holding AG
SIX:ROG
202.8B CHF 3.4 24.5 9.2 10.8
CH
Novartis AG
SIX:NOVN
187.7B CHF 4.4 18.2 10.7 14.4
UK
AstraZeneca PLC
LSE:AZN
162.7B GBP 4 28.1 130.4 196.7
US
Merck & Co Inc
NYSE:MRK
205.6B USD 3.2 11.8 8.8 10.6
IE
Endo International PLC
LSE:0Y5F
184.8B USD 79.7 -63.2 294 737.3
US
Pfizer Inc
NYSE:PFE
140.8B USD 2.3 17.9 7.6 10.7
P/E Multiple
Earnings Growth PEG
TH
M
Mega Lifesciences PCL
SET:MEGA
Average P/E: 23.8
12
9%
1.3
US
Eli Lilly and Co
NYSE:LLY
66.5
49%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
17.2
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
18.4
18%
1
CH
Roche Holding AG
SIX:ROG
24.5
32%
0.8
CH
Novartis AG
SIX:NOVN
18.2
17%
1.1
UK
AstraZeneca PLC
LSE:AZN
28.1
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.8
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -63.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
17.9
30%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
TH
M
Mega Lifesciences PCL
SET:MEGA
Average EV/EBITDA: 397.6
5.6
-2%
N/A
US
Eli Lilly and Co
NYSE:LLY
35.7
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.5
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
12.7
13%
1
CH
Roche Holding AG
SIX:ROG
9.2
5%
1.8
CH
Novartis AG
SIX:NOVN
10.7
5%
2.1
UK
AstraZeneca PLC
LSE:AZN
130.4
10%
13
US
Merck & Co Inc
NYSE:MRK
8.8
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
294
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
2%
3.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
TH
M
Mega Lifesciences PCL
SET:MEGA
Average EV/EBIT: 1 705.4
6.1
-2%
N/A
US
Eli Lilly and Co
NYSE:LLY
39
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.5
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
14.6
14%
1
CH
Roche Holding AG
SIX:ROG
10.8
6%
1.8
CH
Novartis AG
SIX:NOVN
14.4
10%
1.4
UK
AstraZeneca PLC
LSE:AZN
196.7
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.6
11%
1
IE
E
Endo International PLC
LSE:0Y5F
737.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.7
10%
1.1